Overview

Pharmacokinetics and Safety of 'CG-745 IV' and 'CG-750' in Healthy Male Adults

Status:
Completed
Trial end date:
2021-05-19
Target enrollment:
Participant gender:
Summary
A randomized, placebo-controlled, dose-escalation, crossover study.
Phase:
Phase 1
Details
Lead Sponsor:
CrystalGenomics, Inc.